Gross Margin
9.23%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 4.64%.Updated Aug 20, 2026Profit Margin
-3.76%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Margin
3.26%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Assets (TTM)
-0.56%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Equity (TTM)
-5.01%vs Specialty Chemicals peers Updated Aug 20, 2026Revenue (TTM)
686.06BKRW494.35M · vs all stocks (USD) Updated Aug 20, 2026Revenue per Share (TTM)
17.89KKRWUpdated Aug 20, 2026Quarterly Revenue Growth
13.60%vs Specialty Chemicals peers Updated Aug 20, 2026Gross Profit (TTM)
31.81BKRW22.92M · vs all stocks (USD) Updated Aug 20, 2026EBITDA (TTM)
12.72BKRW9.17M · vs all stocks (USD) Updated Aug 20, 2026Net Income (TTM)
-25.77BKRW-18.57M · vs all stocks (USD) Updated Aug 20, 2026Quarterly Earnings Growth (YoY)
13.55%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Cash Flow (TTM)
25.27BKRW18.21M · vs all stocks (USD) Updated Aug 20, 2026Levered Free Cash Flow (TTM)
-21.77BKRW-15.69M · vs all stocks (USD) Updated Aug 20, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 20, 2026Minority Interest (Equity)
364.48BKRWFY2025 · Dec 31, 2025Revenue
664.16BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
637.57BKRWFY2025 · Dec 31, 2025Gross Profit
26.58BKRWFY2025 · Dec 31, 2025Operating Income
-15.99BKRW-11.52M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-32.36BKRWFY2025 · Dec 31, 2025Income Tax Expense
-1.40BKRWFY2025 · Dec 31, 2025Net Income
-30.96BKRWFY2025 · Dec 31, 2025EBIT
-14.59BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
12.72BKRWFY2025 · Dec 31, 2025Research & Development
5.43BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
16.55BKRWFY2025 · Dec 31, 2025Other Operating Expenses
1.09BKRWFY2025 · Dec 31, 2025Non-operating Interest Income
1.27BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
17.77BKRWFY2025 · Dec 31, 2025EPS (Basic)
-791.00KRWFY2025 · Dec 31, 2025EPS (Diluted)
-791.00KRWFY2025 · Dec 31, 2025Basic Shares Outstanding
38.36MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
38.36MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-30.96BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
616.78MKRWFY2025 · Dec 31, 2025Operating Cash Flow
117.08BKRWFY2025 · Dec 31, 2025Free Cash Flow
62.38BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
42.47BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-30.96BKRWFY2025 · Dec 31, 2025Other Non-cash Items
16.54BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
64.31BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
67.19BKRWFY2025 · Dec 31, 2025Capital Expenditures
-54.70BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-120.44MKRWFY2025 · Dec 31, 2025Purchase of Investments
-1.24BKRWFY2025 · Dec 31, 2025Sale of Investments
1.37BKRWFY2025 · Dec 31, 2025Other Investing Activity
-1.69BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-56.27BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-342.20BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-25.77BKRWFY2025 · Dec 31, 2025Other Financing Charges
-20.76MKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-367.99BKRWFY2025 · Dec 31, 2025